Company: RGNT
Filing Date: 2025-05-19
Form Type: F-1/A
Source: 0001213900-25-045479
Chunk: 76

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-19
Form: F-1/A
Chunk 76
---
 you may not be able to sell your Ordinary Shares at or above
the initial public offering price. Some of the factors that may cause the market price of our Ordinary Shares to fluctuate include:

| ● | delays or setbacks in the ongoing commercialization of GelrinC; |

| ● | the success of existing or new competitive products or technologies; |

| ● | regulatory or legal developments in the United States and other countries; |

| ● | developments or disputes concerning patent applications, issued patents or other proprietary rights; |

| ● | the recruitment or departure of key personnel; |

| ● | the commencement of litigation; |

<div align='center'>46</div>

| ● | actual or anticipated changes in estimates as to financial results; |

| ● | announcement or expectation of additional financing efforts; |

| ● | sales of our Ordinary Shares by us, our insiders or other shareholders; |

| ● | expiration of market standoff or lock-up agreements; |

| ● | variations in our financial results or those of companies that are perceived to be similar to us; |

| ● | changes in estimates or recommendations by securities analysts, if any, that cover our shares; |

| ● | changes in the structure of health care payment systems; |

| ● | market conditions in the medical device sectors; |

| ● | the seasonality of our business; |

| ● | an increase in the rate of returns of our GelrinC implants or an increase in warranty claims; |

| ● | the impact of any resurgence of COVID-19 or other pandemics on the performance of elective procedures; |

| ● | general economic, industry and market conditions; and |

| ● | the other factors described in this “Risk Factors.” |

In recent years, the stock
market in general, and the market for medical device companies in particular, has experienced significant price and volume fluctuations
that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing
those price and volume fluctuations. Further, the stock market in general has been highly volatile due to recent geopolitical events across
the world. Broad market and industry factors may seriously affect the market price of our Ordinary Shares, regardless of our actual operating
performance. These fluctuations may be even more pronounced in the trading market for our shares shortly following this offering. Following
periods of such volatility in the market price of a company’s securities, securities class action litigation has often been brought
against that company. Because of the potential volatility of our share price, we may become the